Background: The in-depth characterization of the recently identified house dust mite (HDM) major allergen Der p 23 requires the production of its recombinant counterpart because the natural allergen is poorly extractable from fecal pellets. This study aimed to provide a detailed physico-chemical characterization of recombinant Der p 23 (rDer p 23) as well as to investigate its IgE reactivity in a cohort of HDM-allergic patients from Thailand. Methods: Purified rDer p 23, secreted from recombinant Pichia pastoris, was characterized by mass spectrometry and circular dichroism analyses as well as for its chitin-binding activity. The IgE-binding frequency and allergenicity of Der p 23 were determined by ELISA and RBL-SX38 degranulation assays, respectively. Results: Purified intact rDer p 23 carried O-mannosylation and mainly adopted a random coil structure. Polyclonal antibodies to rDer p 23 can detect the corresponding natural allergen (nDer p 23) in aqueous fecal pellet extracts, suggesting that both forms of Der p 23 share common B-cell epitopes. Despite its homologies with chitin-binding proteins, both natural Der p 23 and rDer p 23 were unable to interact in vitro with chitin matrices. Of 222 Thai HDM-allergic patients tested, 54% displayed Der p 23-specific IgE responses. Finally, the allergenicity of rDer p 23 was confirmed by the degranulation of rat basophil leukemia cells. Conclusion: Our findings highlighted important levels of Der p 23 sensitizations in Thailand. Our study clearly suggested that rDer p 23 is likely more appropriate for HDM allergy component-resolved diagnosis than HDM extracts.

Keywords:
IgE reactivity, O-glycosylation, Allergen, Chitin, Der p 23, House dust mite
1.
Zock J-P, Heinrich J, Jarvis D, Verlato G, Norbäck D, Plana E, et al: Distribution and determinants of house dust mite allergens in Europe: the European Community Respiratory Health Survey II. J Allergy Clin Immunol 2006;118:682-690.
2.
Gregory LG, Lloyd CM: Orchestrating house dust mite-associated allergy in the lung. Trends Immunol 2011;32:402-411.
3.
Raulf M, Bergmann KC, Kull S, Sander I, Hilger C, Brüning T, et al: Mites and other indoor allergens - from exposure to sensitization and treatment. Allergol J Int 2015;24:68-80.
4.
Moingeon P: Progress in the development of specific immunotherapies for house dust mite allergies. Expert Rev Vaccines 2014;13:1463-1473.
5.
Bronnert M, Mancini J, Birnbaum J, Agabriel C, Liabeuf V, Porri F, et al: Component-resolved diagnosis with commercially available D. pteronyssinus Der p 1, Der p 2 and Der p 10: relevant markers for house dust mite allergy. Clin Exp Allergy 2012;42:1406-1415.
6.
Weghofer M, Thomas WR, Kronqvist M, Mari A, Purohit A, Pauli G, et al: Variability of IgE reactivity profiles among European mite allergic patients. Eur J Clin Invest 2008;38:959-965.
7.
Weghofer M, Grote M, Resch Y, Casset A, Kneidinger M, Kopec J, et al: Identification of Der p 23, a peritrophin-like protein, as a new major Dermatophagoides pteronyssinus allergen associated with the peritrophic matrix of mite fecal pellets. J Immunol 2013;190:3059-3067.
8.
Hegedus D, Erlandson M, Gillott C, Toprak U: New insights into peritrophic matrix synthesis, architecture, and function. Annu Rev Entomol 2009;54:285-302.
9.
Wiegand TW, Williams PB, Dreskin SC, Jouvin MH, Kinet JP, Tasset D: High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I. J Immunol 1996;157:221-230.
10.
Willer T: O-mannosyl glycans: from yeast to novel associations with human disease. Curr Opin Struct Biol 2003;13:621-630.
11.
Li Y-T: Presence of α-D-mannosidic linkage in glycoproteins. J Biol Chem 1966;241:1010-1012.
12.
Tellam RL, Wijffels G, Willadsen P: Peritrophic matrix proteins. Insect Biochem Mol Biol 1999;29:87-101.
13.
Roy RM, Wüthrich M, Klein BS: Chitin elicits CCL2 from airway epithelial cells and induces CCR2-dependent innate allergic inflammation in the lung. J Immunol 2012;189:2545-2552.
14.
Reese TA, Liang H-E, Tager AM, Luster AD, Van Rooijen N, Voehringer D, et al: Chitin induces accumulation in tissue of innate immune cells associated with allergy. Nature 2007;447:92-96.
15.
Al-Ghouleh A, Johal R, Sharquie IK, Emara M, Harrington H, Shakib F, et al: The glycosylation pattern of common allergens: the recognition and uptake of Der p 1 by epithelial and dendritic cells is carbohydrate dependent. PLoS One 2012;7:e33929.
16.
Kirkland TN, Finley F, Orsborn KI, Galgiani JN: Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice. Infect Immun 1998;66:3519-3522.
17.
Banerjee S, Weber M, Blatt K, Swoboda I, Focke-Tejkl M, Valent P, et al: Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine. J Immunol 2014;192:4867-4875.
18.
Jacquet A: The role of innate immunity activation in house dust mite allergy. Trends Mol Med 2011;17:604-611.
19.
Shen Z: A type I peritrophic matrix protein from the malaria vector Anopheles gambiae binds to chitin. J Biol Chem 1998;273:17665-17670.
20.
Wijffels G, Eisemann C, Riding G, Pearson R, Jones A, Willadsen P, Tellam R: Novel family of chitin-binding proteins from insect type 2 peritrophic matrix. cDNA sequences, chitin binding activity, and cellular localization. J Biol Chem 2001;276:15527-15536.
21.
Zakzuk J, Benedetti I, Fernández-Caldas E, Caraballo L: The influence of chitin on the immune response to the house dust mite allergen Blo t 12. Int Arch Allergy Immunol 2014;163:119-129.
22.
Chan T-F, Ji K-M, Yim AK-Y, Liu X-Y, Zhou J-W, Li R-Q, et al: The draft genome, transcriptome, and microbiome of Dermatophagoides farinae reveal a broad spectrum of dust mite allergens. J Allergy Clin Immunol 2015;135:539-548.
23.
Salazar F, Sewell HF, Shakib F, Ghaemmaghami AM: The role of lectins in allergic sensitization and allergic disease. J Allergy Clin Immunol 2013;132:27-36.
24.
McCall C, Hunter S, Stedman K, Weber E, Hillier A, Bozic C, et al: Characterization and cloning of a major high molecular weight house dust mite allergen (Der f 15) for dogs. Vet Immunol Immunopathol 2001;78:231-247.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.